168 Participants NeededMy employer runs this trial

Abuse Potential for Junk Food

CP
TF
Overseen ByTera Fazzino, Doctorate
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The study will conduct a laboratory study designed to evaluate the rewarding and addictive properties of hyper-palatable foods (HPF), using potato chips as the food stimulus/sample HPF.

Are You a Good Fit for This Trial?

This trial is for adults interested in participating in a study about how certain snack foods, like potato chips, may have addictive qualities. People with food allergies or medical conditions that could be affected by eating these foods likely cannot join.

Inclusion Criteria

High dietary intake of regular potato chips (>=3 times per week) identified via a standard dietary history questionnaire
I am 18 years old or older.
I enjoy potato chips and the study food and am willing to eat them in the lab.

Exclusion Criteria

Trying to cut down on high potato chip food intake
I have a diagnosed problem with my sense of smell or taste.
Dietary allergies or restrictions to gluten
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo four study sessions to evaluate the rewarding and addictive properties of hyper-palatable foods using potato chips as the stimulus.

4 weeks
4 visits (in-person)

Follow-up

Participants are monitored for subjective effects and behavioral responses to food stimuli after the treatment sessions.

4 weeks

What Are the Treatments Tested in This Trial?

Trial Overview

The study compares different types of snack chips: regular hyper-palatable chips, versions without sodium or fat, and a non-addictive vegetable chip (jicama) to see which are most rewarding or potentially addictive.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Group I: Sequence 4: Negative Control → Full Dose HPF → Modified Dose- No Fat → Modified Dose- No SodiumExperimental Treatment4 Interventions
Group II: Sequence 3: Modified Dose- No Sodium → Negative Control → Full Dose HPF → Modified Dose- No FatExperimental Treatment4 Interventions
Group III: Sequence 2: Modified Dose- No Fat → Modified Dose- No Sodium → Negative Control → Full Dose HPFExperimental Treatment4 Interventions
Group IV: Sequence 1: Full Dose HPF → Modified Dose- No Fat → Modified Dose No Sodium → Negative ControlExperimental Treatment4 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Kansas

Lead Sponsor

Trials
157
Recruited
332,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+